Skip To Main Content
This website is intended exclusively for healthcare professionals residing and/or working in the KSA.
Campus
  • Payor
Campus
  • Payor

Nasal Polyps

Get a global overview and learn all about the changing world of Nasal Polyps

Science in Nasal Polyps

Get a 360º view and stay updated on Nasal Polyps with content selected for you

EPOS2020/EUFOREA Expert Opinion on Defining Disease States and Therapeutic Goals in CRSwNP

EPOS2020/EUFOREA Expert Opinion on Defining Disease States and Therapeutic Goals in CRSwNP

An expert panel convened by EPOS2020 and EUFOREA proposed standardized definitions for disease control, remission, and progression in CRSwNP. This initiative aims to harmonize and optimize the standard of care for patients with CRSwNP.

Learn More
Loss of Smell Improvement in Patients With CRSwNP

Loss of Smell Improvement in Patients With CRSwNP

Learn More
Loss of Smell Is a Key Symptom in CRSwNP

Loss of Smell Is a Key Symptom in CRSwNP

Learn More
IL-4 and IL-13 are key and central cytokines with unique and overlapping roles contributing to the pathophysiology of CRSwNP

IL-4 and IL-13 are key and central cytokines with unique and overlapping roles contributing to the pathophysiology of CRSwNP

Learn More
Daily Burden of CRSwNP

Daily Burden of CRSwNP

Learn More
Hear From An Expert On Identify Patients Who Are Appropriate Candidates For Biologic Treatment

Hear From An Expert On Identify Patients Who Are Appropriate Candidates For Biologic Treatment

On average the typical patients with nasal polyps have had +1 sinus surgery, sinus surgery dose not cure the nasal polyps. A medication where i can prevent revision sinus surgery...a good thing for me and for the patient.

Learn More
Hear from an expert on what does Dupixent bring to your practice?

Hear from an expert on what does Dupixent bring to your practice?

Learn More
Expert Opinions: Would You Consider A Biologic For A CRSwnp Patient Who Has Had Sinus Surgery?

Expert Opinions: Would You Consider A Biologic For A CRSwnp Patient Who Has Had Sinus Surgery?

Learn More

Inspiration and innovation

Get inspired and stay at the forefront of innovation with the following resources

EPOS2020/EUFOREA Expert Opinion on Defining Disease States and Therapeutic Goals in CRSwNP

EPOS2020/EUFOREA Expert Opinion on Defining Disease States and Therapeutic Goals in CRSwNP

An expert panel convened by EPOS2020 and EUFOREA proposed standardized definitions for disease control, remission, and progression in CRSwNP. This initiative aims to harmonize and optimize the standard of care for patients with CRSwNP.

Learn More
Loss of Smell Improvement in Patients With CRSwNP

Loss of Smell Improvement in Patients With CRSwNP

Learn More
Loss of Smell Is a Key Symptom in CRSwNP

Loss of Smell Is a Key Symptom in CRSwNP

Learn More
IL-4 and IL-13 are key and central cytokines with unique and overlapping roles contributing to the pathophysiology of CRSwNP

IL-4 and IL-13 are key and central cytokines with unique and overlapping roles contributing to the pathophysiology of CRSwNP

Learn More
Daily Burden of CRSwNP

Daily Burden of CRSwNP

Learn More
Hear from an expert on what does Dupixent bring to your practice?

Hear from an expert on what does Dupixent bring to your practice?

Learn More
Expert Opinions: Would You Consider A Biologic For A CRSwnp Patient Who Has Had Sinus Surgery?

Expert Opinions: Would You Consider A Biologic For A CRSwnp Patient Who Has Had Sinus Surgery?

Learn More
Hear from an expert on how does Dupixent target Underlying Type 2 Inflammation?

Hear from an expert on how does Dupixent target Underlying Type 2 Inflammation?

Learn More